首页> 外文期刊>Cytotherapy >Roadmap to approval: use of an automated sterility test method as a lot release test for Carticel (R), autologous cu1ltured chondrocytes
【24h】

Roadmap to approval: use of an automated sterility test method as a lot release test for Carticel (R), autologous cu1ltured chondrocytes

机译:批准路线图:使用自动无菌测试方法作为Carticel(R)自体培养软骨细胞的批量释放测试

获取原文
获取原文并翻译 | 示例
           

摘要

Background In February 2004, FDA approved a supplement to our biologics license for Carticel(R), autologous cultured chondrocytes, to use the BacT/ALERT(R) microbial detection system as an alternative to the compendial sterility test for lot release. This article provides a roadmap to our approval process. The approval represents more than 4 years of development and validation studies comparing the Steritest(TM) compact system to the BacT/ALERT(R) microbial detection system. Methods For this study, freshly cultured chondrocytes were prepared from a characterized cell bank. Microbial isolates were prepared from either American Type Culture Collection (ATCC) strains or from in-house contaminants. For each test condition, a suspension of chondrocyte cells and test organisms was inoculated into both aerobic media (SA(TM) standard adult culture bottles, FA(TM) FAN, tryptic soy broth) and anaerobic media (SN(TM)) standard adult culture bottles, FN(TM) FAN, fluid thioglycollate media) and tested for sterility using the Steritest(TM) compact system (Millipore, Bedford, MA, USA) and the BacT/ALERT(R) microbial detection system (bioMerieux, Durham, NC, USA). Negative control bottles were inoculated with chondrocytes and no microorganisms. All bottles were incubated for 14 days and read daily. Bacterial growth was determined by either visual examination of Steritest(TM) canisters or detection of a positive by the BacT/ALERT(R) system. A gram stain and streak plate were used to confirm positive bottles and negative bottles after 14 days. Results The detection of a positive by either the Steritest(TM) compact system or the BacT/ALERT(R) system was summarized for each organism in each validation study. Data generated from studies reducing the incubation temperature from 35 degrees C to 32 degrees C improved detection times in the automated method compared with the compendial method. Other improvements included the use of FAN aerobic and anaerobic media to absorb the gentamicin contained in the culture media of prepared chondrocyte samples. Chondrocytes alone did not generate positive results in either the compendial method or the automated method. Discussion Data from validation studies support the use of the BacT/ALERT(R) microbial detection system as an alternative sterility test for Carticel(R).
机译:背景技术2004年2月,FDA批准了自体培养软骨细胞Carticel(R)的生物制剂许可的补充,以使用BacT / ALERT(R)微生物检测系统作为批注无菌试验的替代方法。本文提供了我们批准流程的路线图。该批准代表了将Steritest(R)紧凑型系统与BacT / ALERT(R)微生物检测系统进行比较的4年多的开发和验证研究。方法为了进行这项研究,从有特征的细胞库中制备新鲜培养的软骨细胞。微生物分离株是从美国典型培养物保藏中心(ATCC)菌株或内部污染物中制备的。对于每种测试条件,将软骨细胞和测试生物的悬浮液接种到需氧培养基(SA™标准成人培养瓶,FA™FAN,胰蛋白酶大豆肉汤)和厌氧培养基(SN™)标准成人中培养瓶,FN(TM)FAN,液体巯基乙酸盐介质),并使用Steritest(TM)紧凑型系统(美国马萨诸塞州贝德福德的Millipore)和BacT / ALERT(R)微生物检测系统(bioMerieux,Durham,美国北卡罗来纳州)。阴性对照瓶接种软骨细胞,不接种微生物。将所有瓶温育14天并每天阅读。通过目视检查Steritest TM罐或通过BacT / ALERT系统检测阳性来确定细菌的生长。 14天后,使用克污渍和划线板确认阳性瓶和阴性瓶。结果在每个验证研究中总结了每种生物通过SteritestTM紧凑系统或BacT /ALERT®系统检测到的阳性结果。从研究中将孵育温度从35摄氏度降低到32摄氏度的研究产生的数据与自动方法相比,缩短了检测时间。其他改进包括使用FAN好氧和厌氧培养基吸收制备的软骨细胞样品培养基中所含的庆大霉素。单独的软骨细胞在纲要法或自动化方法中均未产生阳性结果。讨论来自验证研究的数据支持使用BacT / ALERT(R)微生物检测系统作为Carticel(R)的替代无菌测试。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号